Designing immunotoxins for cancer therapy

Author： Pennell Christopher Erickson Heidi

ISSN： 0257-277X

Source： Immunologic Research, Vol.25, Iss.2, 2002-04, pp. : 177-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenomics and epigenetic therapy of cancer

By Brown R. Strathdee G.

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

The prospects for cancer gene therapy

By De Giovanni C. Nanni P. Forni G.

International Journal of Immunopharmacology, Vol. 22, Iss. 12, 2000-12 ,pp. : 1025-1032

Elsevier

Access to resources Recommend Favorite

Serpins for Diagnosis and Therapy in Cancer

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 13, Iss. 2, 2013-07 ,pp. : 123-132

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Immunotherapy and Immunomonitoring (CITIM): Redefining Cancer Therapy

By Malyguine Anatoli Umansky Victor Shurin Michael R.

Journal of Immunotoxicology, Vol. 6, Iss. 4, 2009-12 ,pp. : 205-208

Informa Healthcare

Access to resources Recommend Favorite

Antibody-based therapy in colorectal cancer

By Noguchi Takuro Ritter Gerd Nishikawa Hiroyoshi

Immunotherapy, Vol. 5, Iss. 5, 2013-05 ,pp. : 533-545

Future Medicine

Access to resources Recommend Favorite